Marks Group Wealth Management’s Boston Scientific BSX Stock Holding History

Marks Group Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Buy	77,236 +74,005	+2,290%	+$4.02M	0.29%	91
2026 Q1	$203K	Buy	3,231 +139	+4%	+$11.1K	0.02%	331
2025 Q4	$295K	Sell	3,092 -160	-5%	-$15.7K	0.03%	287
2025 Q3	$317K	Sell	3,252 -1,363	-30%	-$141K	0.03%	254
2025 Q2	$496K	Sell	4,615 -268	-5%	-$27.1K	0.05%	224
2025 Q1	$493K	Sell	4,883 -104,358	-96%	-$10.5M	0.05%	243
2024 Q4	$9.76M	Sell	109,241 -4,676	-4%	-$412K	0.96%	21
2024 Q3	$9.55M	Buy	113,917 +615	+0.5%	+$48.5K	0.91%	28
2024 Q2	$8.73M	Sell	113,302 -11,705	-9%	-$857K	0.92%	23
2024 Q1	$8.56M	Sell	125,007 -1,416	-1%	-$91K	0.9%	34
2023 Q4	$7.31M	Sell	126,423 -625	-0.5%	-$33.4K	0.83%	40
2023 Q3	$6.71M	Buy	127,048 +1,409	+1%	+$73.9K	0.83%	44
2023 Q2	$6.8M	Buy	+125,639	New	+$6.56M	0.81%	50

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marks Group Wealth Management's BSX Position: Q2 2026 in Review

Marks Group Wealth Management increased its Boston Scientific (BSX) stake by 2,290% in Q2 2026, buying an estimated $4.02M and bringing the position to 77,236 shares worth $3.3M. The position accounts for 0.29% of the portfolio, ranked #91.

Marks Group Wealth Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.76M in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Marks Group Wealth Management held 77,236 shares of Boston Scientific worth $3.3M as of Q2 2026.
Marks Group Wealth Management bought 74,005 Boston Scientific shares in Q2 2026, an estimated $4.02M.
Boston Scientific made up 0.29% of Marks Group Wealth Management's portfolio in Q2 2026, its #91 holding.
Marks Group Wealth Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
Marks Group Wealth Management's Boston Scientific position peaked at $9.76M in Q4 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.